Sio Gene Therapies Inc. Current Assets
Sio Gene Therapies Inc. had Current Assets of $47.27 million as of 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2023-02-14
- 2022-12-31: Assets, Current $47.27M.
- 2022-09-30: Assets, Current $53.74M.
- 2022-06-30: Assets, Current $59.13M.
- 2022-03-31: Assets, Current $71.74M.
| Period end | Assets, Current |
|---|---|
| 2022-12-31 | $47.27M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $53.74M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $59.13M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $71.74M 10-Q · filed 2023-02-14 |
| 2021-12-31 | $90.07M 10-Q · filed 2022-02-11 |
| 2021-09-30 | $108.93M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $118.93M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $132.33M 10-K · filed 2022-06-14 |
| 2020-12-31 | $97.03M 10-Q · filed 2021-02-09 |
| 2020-09-30 | $70.32M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $61.20M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $85.43M 10-K · filed 2021-06-09 |
| 2019-12-31 | $33.42M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $66.83M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $91.75M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $114.58M 10-K · filed 2020-06-10 |
| 2018-12-31 | $91.40M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $96.35M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $102.00M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $158.26M 10-K · filed 2019-06-11 |
| 2017-12-31 | $193.14M 10-Q · filed 2018-02-09 |
| 2017-09-30 | $242.77M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $306.71M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $219.69M 10-K · filed 2018-06-11 |
| 2016-12-31 | $205.58M 10-Q · filed 2017-02-14 |
| 2016-09-30 | $234.44M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $256.75M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $282.09M 10-K · filed 2017-06-13 |
| 2015-12-31 | $303.82M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $322.51M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $331.10M 10-Q · filed 2015-08-11 |
| 2015-03-31 | $1.11M 10-K · filed 2016-06-06 |